Clinical Trial Information
Principal Invesitator - Michael Rickels, MD, MS
Title: Residual C-peptide in Patients with Type 1 Diabetes
Sponsor: The Jaeb Center for Health Research in Tampa, Florida.
Objective: This is a T1D Registry Ancillary Study. This study aims to determine the prevalence of residual C-peptide in individuals with Type 1 Diabetes. according to
duration of disease and age of onset.
Eligibility: Enrollment into this study is now closed. The study enrolled approximately1000 individuals with T1D in subgroups of approximately 100. The subgroups were based on duration of T1D and on age at diagnosis
Nora Rosenfeld, CRC